OrderlyMeds announces online availability of compounded GLP-1 and GIP medications, including Tirzepatide and Semaglutide, on a monthly prescription. The platform reports over 57,000 customers have documented weight loss on the medically-supervised program.
-- OrderlyMeds has launched expanded online access to compounded Semaglutide and Tirzepatide medications, offering compounded GLP-1 injections and compounded GLP-1/GIP injections to help with weight loss. The announcement positions affordability and accessibility as central differentiators for individuals pursuing weight management or diabetes solutions through these therapeutic options.
More information is available at https://orderlymeds.com/treatments/glp1s/compounded-glp1-gip/
The availability of these medications responds to growing demand driven by rising rates of obesity and diabetes prevalence in American adults. Traditional healthcare channels often fail to address these conditions with sufficient speed or cost-effectiveness. However, OrderlyMeds reports that over 57,000 customers have documented weight loss through its platform, contributing to more than 1 million total pounds lost. Customers on the company's 3-month starter plan have achieved an average reduction of 15 pounds, demonstrating measurable outcomes that validate the clinical relevance of this announcement.
For safety, the program is medically-supervised. Access to the program requires individuals to be at least 18 years old, with a body mass index greater than 25 for those new to GLP-1 medications or greater than 20 for those already using them. OrderlyMeds structures onboarding through its SimpleStart program, which initiates new users with a three-month titration schedule. Compounded GLP-1/GIP (Tirzepatide) begins at 2.5mg, while compounded GLP-1 (Semaglutide) starts at 0.25mg, with doses adjusted to monitor tolerance and response on the advice of the company's medical specialists.
Once a patient submits their information, the company's medical team reviews and approves prescriptions within 24-48 hours. The pharmacy processes and ships orders within 2-3 days after approval. Customers can expect to receive their medication within 8-10 business days of signing up, providing a predictable pathway from consultation to receipt.
Prospective patients can be reassured that the compounded medications distributed by OrderlyMeds are prepared in facilities licensed by state Boards of Pharmacy or registered with the FDA as outsourcing facilities, which mandate the use of ingredients sourced from FDA-licensed suppliers. These facilities test sterile compounds for potency, sterility, and purity as part of their quality assurance protocols. The FDA has clarified that compounded drugs are not FDA-approved and do not undergo the agency's pre-market review for safety, effectiveness, or quality, a distinction OrderlyMeds acknowledges while emphasizing adherence to rigorous facility standards.
OrderlyMeds provides comprehensive access to weight management and diabetes solutions through its online platform. Additional details are available at https://orderlymeds.com/
Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/
Source: PressCable
Release ID: 89183090
If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.
